Icagen and Pfizer Form Three Way Collaboration with Yale To Explore Chronic Pain Remedies
Chronic pain and epilepsy are debilitating disorders that affect millions of individuals in the US and throughout the world.
Chronic pain and epilepsy are debilitating disorders that affect millions of individuals in the US and throughout the world.
Although back pain is common, it can be difficult for physicians to determine the exact cause of the pain using current testing methods.
MicroTransponder is developing a wireless neurostimulation device for the treatment of chronic pain.
Pharmaceutical company MediciNova announced that it will buy Avigen (AVGN) for $1.24 per share, approximately $37 million.
CombinatoRx has signed an all-stock merger agreement with Neuromed.
Copyright © 2025 | WordPress Theme by MH Themes